@article {5347,
	title = {Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.},
	journal = {Journal of substance abuse treatment},
	volume = {68},
	year = {2016},
	month = {2016 Sep},
	pages = {62-7},
	abstract = {Individuals with HIV and hepatitis C (HCV) infection, alcohol use disorder, or who are prescribed potentially hepatotoxic medications may be at increased risk for buprenorphine (BUP) associated hepatotoxicity.},
	issn = {1873-6483},
	doi = {10.1016/j.jsat.2016.06.002},
	author = {Tetrault, Jeanette M and Tate, Janet P and Edelman, E Jennifer and Gordon, Adam J and Lo Re, Vincent and Lim, Joseph K and Rimland, David and Goulet, Joseph and Crystal, Stephen and Gaither, Julie R and Gibert, Cynthia L and Rodriguez-Barradas, Maria C and Fiellin, Lynn E and Bryant, Kendall and Justice, Amy C and Fiellin, David A}
}
